| Name | Title | Contact Details |
|---|
Hillsboro Medical Ctr is a Hillsboro, ND-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Prism Health Networks is a Buffalo, NY-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Deering Community Health Center is a Billings, MT-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Founded in 1924, Baptist Health has been bringing advanced medical technology, modern facilities, and many of the region`s most prominent physicians and medical professionals to the communities of our commonwealth for nearly a century. Headquartered in Louisville, the Baptist Health family of hospitals, care centers, physician offices and health facilities has experienced tremendous growth in recent years. Baptist Health Floyd in New Albany, Ind. (formerly known as Floyd Memorial Hospital and Health Services), is the newest member, joined on Oct. 1, 2016. In 2012, we welcomed Baptist Health Richmond (formerly Pattie A. Clay Regional Medical Center) and Baptist Health Madisonville (formerly Trover Health System) to the fold. Our other hospitals include Baptist Health Paducah, Baptist Health Louisville, Baptist Health La Grange, Baptist Health Lexington and Baptist Health Corbin. We also manage Hardin Memorial Health in Elizabethtown. Counting all nine hospitals, we have more than 2,700 licensed beds. Baptist Health`s 250+ outpatient facilities offer Urgent Care, Express Care, Occupational Medicine, Physical Therapy, Diagnostics and Home Care services. Our physician network of more than 3,000 employed and affiliated physicians continues to grow as we endeavor to improve access to healthcare and enhance the health of Kentucky as a whole.
We are a biopharmaceutical company developing first-in-class therapies for cancer. Imetelstat, a novel, first-in-class telomerase inhibitor, is our product candidate in clinical development. Telomerase enables cancer cells to maintain telomere length, which provides them with the capacity for limitless cellular replication. Imetelstat is a potent and specific inhibitor of telomerase. Based on clinical data we obtained in late 2012, we may develop imetelstat to treat one or more hematologic myeloid malignancies such as myelofibrosis, or MF, myelodysplastic syndromes, or acute myelogenous leukemia.